NLS Days – time to sign up

Oslo Cancer Cluster is one of the supporting organizations for this years Nordic Life Science Days in Stockholm. Members of the cluster benefit from special rates on participation plus we host an Oncology 2025 Super Session.

In collaboration with LMI, Nansen Neuroscience Network and other healthcare industry actors in Norway, Oslo Cancer Cluster will attend NLSDays to promote Norwegian Healthcare Industry and the cluster members.

Questions regarding the conference may be directed to Jutta Heix, International Advisor or Elisabeth Kirkeng Andersen, Head of Communicaton.

Read the latest newsletter from NLSDays 2015 below or online

The 3rd annual Nordic Life Science Days partnering conference will take place September 9–10 in Stockholm, Sweden, at the Waterfront. NLSDays Super Sessions and Workshops feature top industry leaders and executives speaking on relevant trends to industry decision makers.


Already 50+ Company Presentations confirmed

Presenting at NLSDays is the perfect chance to increase your visibility and attract more partners. Pitch your company’s profile, strategy and objectives to a global audience. Be seen by BD executives, investors, analysts, media and get more activity in partneringONE®. Still a few 6mn and 12mn available slots, don’t miss the opportunity to book your presentation when registering.


Already 50+ Exhibitors confirmed
NLSDays brings hundreds of Life Science Industry leaders from 30+ countries together for 2 days of intensive networking. As an exhibitor, you will reach high-level executives and influential decision makers who come to NLSDays to meet with new players in the industry and initiate partnerships. Still a few 4sqm, 6sqm and 9sqm available stands, don’t miss the opportunity to book yours now.


Oncology 2025 Super Session
Hosted by Oslo Cancer Cluster. Oncology is at the forefront of realizing the promises of precision medicine. Huge and complex datasets are exploited for novel drugs devolpment as well as for informed and real-time care decisions. Emerging cancer immunotherapies represent a paradigm shift for cancer treatment triggening a global R&D race and novel partnerships. Furthermore, the convergence of the genetics and digital revolution creates novel types of products, companies and growth opportunities transforming the sector.


International Investors Super Session

Hosted by Business Sweden, co-hosted by Industrifonden and HealthCap. Meet the investors actively investing in European Life Sciences companies. What are they looking for? What are the learnings in biotech and medtech investing over the past decade? How are these learnings being applied in current investments decisions? How is the financial climate in Life Sciences today?


Member of a supporting organization?
Since Oslo  Cancer Cluster is a supporting organization, members get a discount. Send an e-mail to Elisabeth Kirkeng Andersen, Head of Communicaton to get the Promotion Code and benefit from discount on all registration fees. Remember that Regular Rate registration period ends on June 30, 2015.


Interested in
sponsoring, exhibiting, presenting ? Contact: Olivier Duchamp, olivier.duchamp@bionordic.org

Print This Post